Anest Iwata (6381) Earnings: Operating Profit Up 32.8% YoY to 1.23 Billion Yen

Anest Iwata (6381) announced its latest financial results, reporting net sales of 13.7 billion yen, representing a 13.3% increase year-on-year. Operating profit grew significantly by 32.8% to 1.234 billion yen. Furthermore, ordinary profit reached 1.763 billion yen (a 34.1% increase YoY), and net income attributable to owners of the parent rose 27.0% to 1.137 billion yen, reflecting a strong performance across all major profit categories. Comprehensive income stood at 1.883 billion yen, with earnings per share (EPS) of 28.92 yen.

From a financial structure and cash flow perspective, the company maintains a solid equity ratio of 66.6%, demonstrating financial stability. Cash and cash equivalents reached 18.1 billion yen, while retained earnings totaled 41.89 billion yen, comfortably exceeding interest-bearing debt of 1.08 billion yen. Additionally, operating cash flow showed a strong positive influx of 8.15 billion yen, and free cash flow after capital expenditures registered at 3.82 billion yen, highlighting the company's robust cash-generating capabilities.